Literature DB >> 22251551

Pathological complete response of synchronous multiple liver metastases associated with advanced gastric cancer to gastrectomy and prompt S-1 treatment in combination with fractional cisplatin: report of a case.

Souya Nunobe1, Takashi Kiyokawa, Fumihiko Hatao, Ikuo Wada, Nobuyuki Shimizu, Sachiyo Nomura, Yoshihiro Mise, Yasuhiko Sugawara, Norihiro Kokudo, Yasuyuki Seto.   

Abstract

Systemic chemotherapy is the treatment recommended for prolonged survival in cases of metastatic gastric cancer. There have been a number of clinical reports of surgical resection of liver metastasis in selected patients with gastric cancer. Here, we report on a case of treatment of far advanced gastric cancer with synchronous multiple liver metastases with prompt S-1 in combination with fractional cisplatin sandwiched between twostage surgery. Metastases including peritoneal dissemination and extensive lymph node involvement were absent so it was feasible to completely remove all of the macroscopic liver metastases. Each step of the chemotherapy progressed satisfactorily and histological examination after the hepatectomy yielded a pathologically complete response of liver metastases from the gastric cancer. This strategy provides a promising treatment for far advanced gastric cancer with a limited number of synchronous liver metastases. The referral to surgical oncology is a crucial step for the documentation of pathological complete response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22251551     DOI: 10.5754/hge10238

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  1 in total

1.  Hepatic sinusoidal obstruction associated with S-1 plus cisplatin chemotherapy for highly advanced gastric cancer with paraaortic lymph node metastases: report of a case.

Authors:  Hirofumi Toi; Yosuke Miura; Susumu Shibasaki; Kenji Chisaka; Manabu Goto; Ichiro Tsuda; Takahisa Nakamura; Taiji Hase
Journal:  Clin J Gastroenterol       Date:  2012-09-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.